BR1100696A - Composition consisting essentially of a pharmaceutically acceptable carrier, a free prostaglandin and a particle - Google Patents

Composition consisting essentially of a pharmaceutically acceptable carrier, a free prostaglandin and a particle

Info

Publication number
BR1100696A
BR1100696A BR1100696-0A BR1100696A BR1100696A BR 1100696 A BR1100696 A BR 1100696A BR 1100696 A BR1100696 A BR 1100696A BR 1100696 A BR1100696 A BR 1100696A
Authority
BR
Brazil
Prior art keywords
particle
pharmaceutically acceptable
acceptable carrier
consisting essentially
composition consisting
Prior art date
Application number
BR1100696-0A
Other languages
Portuguese (pt)
Inventor
Andrew S Janoff
David F Eierman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to BR1100696-0A priority Critical patent/BR1100696A/en
Publication of BR1100696A publication Critical patent/BR1100696A/en

Links

BR1100696-0A 1994-01-11 1997-05-08 Composition consisting essentially of a pharmaceutically acceptable carrier, a free prostaglandin and a particle BR1100696A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR1100696-0A BR1100696A (en) 1994-01-11 1997-05-08 Composition consisting essentially of a pharmaceutically acceptable carrier, a free prostaglandin and a particle

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17973994A 1994-01-11 1994-01-11
BR1100696-0A BR1100696A (en) 1994-01-11 1997-05-08 Composition consisting essentially of a pharmaceutically acceptable carrier, a free prostaglandin and a particle

Publications (1)

Publication Number Publication Date
BR1100696A true BR1100696A (en) 2000-07-18

Family

ID=25663618

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100696-0A BR1100696A (en) 1994-01-11 1997-05-08 Composition consisting essentially of a pharmaceutically acceptable carrier, a free prostaglandin and a particle

Country Status (1)

Country Link
BR (1) BR1100696A (en)

Similar Documents

Publication Publication Date Title
HK1015269A1 (en) Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
HUP9601698A3 (en) Pharmaceutical composition of adiabetical activity
AU1590995A (en) Novel carbamate derivative and medicinal composition containing the same
LU91655I2 (en) Corifollitropin alfa and its pharmaceutically acceptable derivatives (ELONVA®)
BR9707411A (en) Polymerizable dental composition and polymerizable compound
HK1010830A1 (en) Pharmaceutical compositions of cyclosporine with a polyethoxylated saturated hydroxy-fatty acid
HUP9900457A3 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
HUP9601566A2 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
PT1005328E (en) COMPOSITION UNDERSTANDING PARTICLES OF BUDSONIDO CRYSTALLINES FINALLY DIVIDED
HU9502918D0 (en) Pharmaceutical composition of antihypertriglyceridemic activity
AU2630295A (en) 2-acylaminopropanol compound and medical composition
EE04681B1 (en) 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition
HUP9901336A3 (en) Heteroaryl-substituted acryloylguanidine derivatives and medicinal composition thereof
AU7550994A (en) Sustained release oral compositions containing melatonin
IL116190A (en) Eleutherobin, analogs thereof and pharmaceutical compositions containing them
AU5630694A (en) Novel physiologically active compound HS-1 and process for the preparation of the same
AU4468093A (en) Composition and methods for the generation of bone
AU4276496A (en) 3-Thioheteroaryl cephalosporin compounds, compositions and methods of use
AU3191597A (en) Novel medicinal compositions of hydropyridines
AU5033296A (en) Antidepressant heteroarylaminoalkyl derivatives of naphthyl-monazines
BR1100696A (en) Composition consisting essentially of a pharmaceutically acceptable carrier, a free prostaglandin and a particle
AU5219798A (en) Gpi-ceruloplasmin, analogs thereof, and methods of use
HU9502509D0 (en) Use of 1,4-dihydropyridine-3,5-dicarboxylic-acid-esters as active component of pharmaceutical compositions
HU9800623D0 (en) Oral application of "(+)-o-demethyl-tramadol as analgesic active component
ITMI931371A1 (en) PROCEDURE FOR THE PREPARATION OF ERDOSTEIN

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
HHFK Processing applications according to articles 230 and 231 of law 9.279/96: republication
MT Patent suspended - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96
HKAN Grant procedure suspended (correction) - according to articles 230 and 231 of law 9279/96